Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.

Standard

Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. / Fischer, Benedikt; Oviedo-Joekes, Eugenia; Blanken, Peter; Haasen, Christian; Rehm, Jürgen; Schechter, Martin T; Strang, John; van den Brink, Wim.

in: J URBAN HEALTH, Jahrgang 84, Nr. 4, 4, 2007, S. 552-562.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Fischer, B, Oviedo-Joekes, E, Blanken, P, Haasen, C, Rehm, J, Schechter, MT, Strang, J & van den Brink, W 2007, 'Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.', J URBAN HEALTH, Jg. 84, Nr. 4, 4, S. 552-562. <http://www.ncbi.nlm.nih.gov/pubmed/17562183?dopt=Citation>

APA

Fischer, B., Oviedo-Joekes, E., Blanken, P., Haasen, C., Rehm, J., Schechter, M. T., Strang, J., & van den Brink, W. (2007). Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J URBAN HEALTH, 84(4), 552-562. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17562183?dopt=Citation

Vancouver

Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT et al. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J URBAN HEALTH. 2007;84(4):552-562. 4.

Bibtex

@article{2b673c50e3c742f8a416b36495e6433a,
title = "Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.",
abstract = "Since the initial Swiss heroin-assisted treatment (HAT) study conducted in the mid-1990s, several other jurisdictions in Europe and North America have implemented HAT trials. All of these studies embrace the same goal-investigating the utility of medical heroin prescribing for problematic opioid users-yet are distinct in various key details. This paper briefly reviews (initiated or completed) studies and their main parameters, including primary research objectives, design, target populations, outcome measures, current status and-where available-key results. We conclude this overview with some final observations on a decade of intensive HAT research in the jurisdictions examined, including the suggestion that there is a mounting onus on the realm of politics to translate the-largely positive-data from completed HAT science into corresponding policy and programming in order to expand effective treatment options for the high-risk population of illicit opioid users.",
author = "Benedikt Fischer and Eugenia Oviedo-Joekes and Peter Blanken and Christian Haasen and J{\"u}rgen Rehm and Schechter, {Martin T} and John Strang and {van den Brink}, Wim",
year = "2007",
language = "Deutsch",
volume = "84",
pages = "552--562",
journal = "J URBAN HEALTH",
issn = "1099-3460",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "4",

}

RIS

TY - JOUR

T1 - Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.

AU - Fischer, Benedikt

AU - Oviedo-Joekes, Eugenia

AU - Blanken, Peter

AU - Haasen, Christian

AU - Rehm, Jürgen

AU - Schechter, Martin T

AU - Strang, John

AU - van den Brink, Wim

PY - 2007

Y1 - 2007

N2 - Since the initial Swiss heroin-assisted treatment (HAT) study conducted in the mid-1990s, several other jurisdictions in Europe and North America have implemented HAT trials. All of these studies embrace the same goal-investigating the utility of medical heroin prescribing for problematic opioid users-yet are distinct in various key details. This paper briefly reviews (initiated or completed) studies and their main parameters, including primary research objectives, design, target populations, outcome measures, current status and-where available-key results. We conclude this overview with some final observations on a decade of intensive HAT research in the jurisdictions examined, including the suggestion that there is a mounting onus on the realm of politics to translate the-largely positive-data from completed HAT science into corresponding policy and programming in order to expand effective treatment options for the high-risk population of illicit opioid users.

AB - Since the initial Swiss heroin-assisted treatment (HAT) study conducted in the mid-1990s, several other jurisdictions in Europe and North America have implemented HAT trials. All of these studies embrace the same goal-investigating the utility of medical heroin prescribing for problematic opioid users-yet are distinct in various key details. This paper briefly reviews (initiated or completed) studies and their main parameters, including primary research objectives, design, target populations, outcome measures, current status and-where available-key results. We conclude this overview with some final observations on a decade of intensive HAT research in the jurisdictions examined, including the suggestion that there is a mounting onus on the realm of politics to translate the-largely positive-data from completed HAT science into corresponding policy and programming in order to expand effective treatment options for the high-risk population of illicit opioid users.

M3 - SCORING: Zeitschriftenaufsatz

VL - 84

SP - 552

EP - 562

JO - J URBAN HEALTH

JF - J URBAN HEALTH

SN - 1099-3460

IS - 4

M1 - 4

ER -